GSTM1 and chronic kidney disease: Observational studies also reported a 13% increased risk of hospitalizations for patients with low hematocrits [5,6], as well as 6% increased risk of cardiovascular events per 10 g/L decrease in hemoglobin (Hb), for patients with anemia in CKD [7].